19
Participants
Start Date
November 4, 2019
Primary Completion Date
April 30, 2024
Study Completion Date
April 30, 2024
Nicotine Containing ECIG with tobacco flavor
"Participants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a vape pen-style device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 18mg/ml nicotine concentration and a tobacco flavor."
Nicotine Containing ECIG with Strawberry Vanilla Flavor
"Participants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a vape pen-style device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 18mg/ml nicotine concentration and a strawberry vanilla flavor."
Placebo ECIG with Tobacco Flavor
"Participants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a vape pen-style device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 0mg/ml nicotine concentration and a tobacco flavor."
Placebo ECIG with Strawberry Vanilla Flavor
"Participants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a vape pen-style device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 0mg/ml nicotine concentration and a strawberry vanilla flavor."
Penn State Health, Hershey
National Institute on Drug Abuse (NIDA)
NIH
Milton S. Hershey Medical Center
OTHER